JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scope & Guideline

Unveiling New Horizons in Cardiovascular and Pulmonary Medicine

Introduction

Welcome to your portal for understanding JOURNAL OF HEART AND LUNG TRANSPLANTATION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1053-2498
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ HEART LUNG TRANSPL / J. Heart Lung Transplant.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Heart and Lung Transplantation focuses on advancing the science and practice of organ transplantation, particularly concerning heart and lung procedures. It aims to disseminate groundbreaking research, clinical experiences, and consensus guidelines that shape the future of transplantation practices.
  1. Clinical Outcomes and Patient Management:
    The journal emphasizes studies related to clinical outcomes in heart and lung transplant recipients, focusing on patient management strategies, post-operative care, and long-term follow-up.
  2. Innovative Transplant Techniques and Technologies:
    It highlights advancements in surgical techniques, mechanical circulatory support devices, and organ preservation technologies, showcasing how these innovations improve transplantation success.
  3. Immunology and Rejection Mechanisms:
    Research related to immune responses, including antibody-mediated rejection and the role of different immunosuppressive therapies, is a core focus, exploring how these factors influence graft survival.
  4. Socioeconomic and Racial Disparities:
    The journal addresses disparities in transplantation outcomes based on socioeconomic status and race, aiming to bring attention to inequalities in access to transplant services.
  5. Emerging Therapies and Biomarkers:
    It includes studies on new therapeutic approaches, biomarker identification for predicting rejection, and monitoring graft health, contributing to personalized medicine in transplantation.
The Journal of Heart and Lung Transplantation has been at the forefront of several emerging themes that reflect the current trends in transplantation science and practice. These trends highlight the journal's commitment to addressing contemporary challenges and innovations in the field.
  1. Donor-Derived Cell-Free DNA Monitoring:
    The use of donor-derived cell-free DNA as a biomarker for graft health and rejection surveillance has gained prominence, reflecting an increasing interest in non-invasive monitoring techniques.
  2. Telehealth and Remote Monitoring:
    With the rise of digital health, studies exploring telehealth applications for monitoring transplant recipients and improving patient engagement are trending, particularly in the context of the COVID-19 pandemic.
  3. Holistic Approaches to Patient Care:
    There is a growing emphasis on the psychosocial aspects of transplantation, including caregiver support, mental health interventions, and quality of life assessments for patients.
  4. Personalized Medicine in Transplantation:
    Research focused on tailoring immunosuppressive therapies based on individual patient and donor characteristics is emerging as a crucial area, promoting better outcomes.
  5. Integration of Machine Learning and AI in Transplantation:
    The application of machine learning models to predict transplant outcomes and assess risk factors is becoming increasingly popular, facilitating data-driven decision-making in clinical practice.

Declining or Waning

As the field of organ transplantation evolves, certain themes within the Journal of Heart and Lung Transplantation have shown a decline in focus. This could reflect shifts in clinical priorities, research funding, or advancements in technology that render previously critical areas less prominent.
  1. Traditional Immunosuppression Protocols:
    There is a noticeable decrease in studies focused solely on traditional immunosuppressive regimens, as newer therapies and personalized approaches gain traction.
  2. Longitudinal Studies on Aging Donor Organs:
    Research centered on the aging of donor organs and its effects on transplantation outcomes appears to be waning, possibly overshadowed by advancements in organ preservation and procurement techniques.
  3. Basic Science Studies on Transplant Immunology:
    While fundamental research remains important, there has been a shift towards clinical applications and practical outcomes, resulting in fewer basic science studies being published.
  4. Single-Center Studies:
    As multicenter collaborations become more common, the focus on single-center studies is declining, likely due to the need for broader data to support findings.
  5. Historical Case Studies and Anecdotal Evidence:
    The journal has seen a reduction in the publication of historical case studies as the focus shifts to evidence-based practices and current clinical guidelines.

Similar Journals

Vestnik Transplantologii i Iskusstvennyh Organov

Empowering collaboration in the science of transplantation.
Publisher: FEDERAL RESEARCH CENTER TRANSPLANTOLOGY & ARTIFICIAL ORGANS V I SHUMAKOVISSN: 1995-1191Frequency: 4 issues/year

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

PEDIATRIC TRANSPLANTATION

Advancing pediatric health through innovative transplantation research.
Publisher: WILEYISSN: 1397-3142Frequency: 8 issues/year

Pediatric Transplantation is a prestigious academic journal published by Wiley, focusing on the critical field of pediatric organ transplantation. Since its inception in 1997, the journal has played a pivotal role in disseminating groundbreaking research and clinical insights relevant to pediatric health, including both pediatrics and transplantation disciplines. With an impact factor that reflects its significance—ranking in the second quartile (Q2) within both Pediatrics, Perinatology and Child Health and Transplantation categories—it provides a vital platform for researchers and clinicians dedicated to improving outcomes for pediatric transplant patients. Pediatric Transplantation embraces a wide scope of studies, from basic science to clinical trials, promoting collaborations that enhance the well-being of young organ recipients. Published in the United Kingdom, this journal does not operate under an open access model, ensuring that the content is peer-reviewed and of the highest academic rigor. For professionals and scholars seeking to stay at the forefront of pediatric transplantation advancements, Pediatric Transplantation serves as an invaluable resource.

Current Transplantation Reports

Bridging Research and Clinical Excellence in Transplantation
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Transplantation Reports, published by SpringerNature, is a leading journal in the field of transplantation science, offering vital insights into the cutting-edge developments in transplant medicine and related disciplines. With an impressive array of quartile rankings, including Q2 in Nephrology and Transplantation, and Q3 in Hepatology and Immunology for 2023, this journal plays a significant role in bridging research and clinical practice. Focused on fostering innovation, the journal spans a wide spectrum of topics, from surgical advances to immunological considerations of transplant procedures. It serves as an invaluable resource for researchers, healthcare professionals, and students interested in the latest advancements and data in transplantation, recognizing the importance of disseminating knowledge in this evolving field. Although currently not designated as Open Access, it provides rigorous peer-reviewed articles that contribute to the academic community's understanding of transplantation scenarios and challenges faced in clinical settings.

Annals of Thoracic and Cardiovascular Surgery

Unveiling breakthroughs in thoracic and cardiovascular techniques.
Publisher: Int Acad Publishing Co LtdISSN: 1341-1098Frequency: 6 issues/year

Annals of Thoracic and Cardiovascular Surgery is a distinguished open-access journal dedicated to the advancing field of thoracic and cardiovascular surgery. Published by Int Acad Publishing Co Ltd since 2011, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of cardiology, surgery, gastroenterology, and pulmonary medicine. With an ISSN of 1341-1098 and E-ISSN of 2186-1005, it offers an extensive collection of peer-reviewed research and innovative surgical techniques. The journal is headquartered in Japan and remarkably spans a history of convergence from 1998 to 2024, reflecting its ongoing commitment to publish cutting-edge studies that shape modern surgical practices. Ranking in the Q2 and Q3 quartiles across multiple categories, including surgery and cardiology, the journal's Scopus ranks—#210 in Surgery and #211 in Cardiology—underscore its influence and relevance in the academic landscape. Our aim is to foster a deeper understanding of surgical methodologies, critical care, and clinical advancements, thereby serving as an indispensable resource for the global surgical community.

Progress in Transplantation

Elevating Standards in Transplantation Medicine
Publisher: SAGE PUBLICATIONS INCISSN: 1526-9248Frequency: 4 issues/year

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Transplantation and Cellular Therapy

Empowering Discoveries in Cell Biology and Molecular Medicine.
Publisher: ELSEVIER SCIENCE INCISSN: 2666-6375Frequency: 12 issues/year

Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.

Expert Review of Respiratory Medicine

Empowering Professionals with Cutting-Edge Respiratory Insights
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Indian Journal of Transplantation

Advancing Transplantation Knowledge Globally
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-0017Frequency: 4 issues/year

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

Journal of Transplantation

Innovating Transplant Science for Better Outcomes
Publisher: HINDAWI LTDISSN: 2090-0007Frequency: 1 issue/year

The Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.

THORACIC AND CARDIOVASCULAR SURGEON

Advancing the frontiers of thoracic and cardiovascular medicine.
Publisher: GEORG THIEME VERLAG KGISSN: 0171-6425Frequency: 8 issues/year

THORACIC AND CARDIOVASCULAR SURGEON, published by GEORG THIEME VERLAG KG, is a prestigious journal dedicated to the fields of cardiology, cardiovascular surgery, and pulmonary medicine. Since its inception in 1973, the journal has served as a vital platform for disseminating cutting-edge research and innovative techniques, contributing significantly to advancements in patient care and surgical practices. With an emerging recognition evidenced by its category quartiles, ranking Q3 in Cardiology and Cardiovascular Medicine and Q2 in Surgery as of 2023, it positions itself as an essential resource for both clinicians and researchers alike. Although this journal does not currently offer Open Access options, it maintains a strong impact with Scopus rankings that highlight its relevance within the medicine and surgery disciplines. The journal is particularly committed to bridging the gap between theoretical research and practical application, making it crucial for professionals aiming to stay informed on the latest developments in thoracic and cardiovascular health. Join a community of scholars dedicated to excellence in these critical areas of medicine.